These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12910030)

  • 1. [Analysis of drug consumption among ambulatory patients in a drug agency of Northern France (Lens)].
    Brunelle E
    Ann Med Interne (Paris); 2003 Jun; 154 Spec No 1():S15-23. PubMed ID: 12910030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: correlates of use, abuse and dependence.
    Lavie E; Fatséas M; Denis C; Auriacombe M
    Drug Alcohol Depend; 2009 Jan; 99(1-3):338-44. PubMed ID: 18824311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance therapy and 3-year outcome of opioid-dependent prisoners: a prospective study in France (2003-06).
    Marzo JN; Rotily M; Meroueh F; Varastet M; Hunault C; Obradovic I; Zin A
    Addiction; 2009 Jul; 104(7):1233-40. PubMed ID: 19426291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Opioid substitution therapy in France: a physician's overview].
    Michel L
    Ann Pharm Fr; 2009 Sep; 67(5):369-73. PubMed ID: 19695374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [High-dose buprenorphine prescription in southern France from 1999 to 2001].
    Mancini J; Thirion X; Masut A; Ronflé E; Coudert C; Pradel V; Frauger E; Micallef J
    Ann Med Interne (Paris); 2003 Jun; 154 Spec No 1():S7-14. PubMed ID: 12910029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of high dose buprenorphine treatments of opiate dependent outpatients in four healthcare networks.
    De Ducla M; Gagnon A; Mucchielli A; Robinet S; Vellay A
    Ann Med Interne (Paris); 2000 Oct; 151 Suppl B():B9-15. PubMed ID: 11104938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Opiate replacement therapy in France].
    Gatignol C
    Ann Pharm Fr; 2009 Sep; 67(5):360-4. PubMed ID: 19695372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine in primary care: risk factors for treatment injection and implications for clinical management.
    Roux P; Villes V; Blanche J; Bry D; Spire B; Feroni I; Carrieri MP
    Drug Alcohol Depend; 2008 Sep; 97(1-2):105-13. PubMed ID: 18479840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opiate addiction in China: current situation and treatments.
    Tang YL; Zhao D; Zhao C; Cubells JF
    Addiction; 2006 May; 101(5):657-65. PubMed ID: 16669899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzodiazepine prescription for patients in opioid maintenance treatment in Norway.
    Bramness JG; Kornør H
    Drug Alcohol Depend; 2007 Oct; 90(2-3):203-9. PubMed ID: 17478058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-centre observational study of buprenorphine use in 32 Italian drug addiction centres.
    Leonardi C; Hanna N; Laurenzi P; Fagetti R;
    Drug Alcohol Depend; 2008 Apr; 94(1-3):125-32. PubMed ID: 18162330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buprenorphine replacement therapy for adolescents with opioid dependence: early experience from a children's hospital-based outpatient treatment program.
    Levy S; Vaughan BL; Angulo M; Knight JR
    J Adolesc Health; 2007 May; 40(5):477-82. PubMed ID: 17448411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
    Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
    Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment options for opiate addiction.
    J Ky Med Assoc; 2004 May; 102(5):221-4. PubMed ID: 15152448
    [No Abstract]   [Full Text] [Related]  

  • 15. Emergency management of inadvertent accelerated opiate withdrawal in dependent opiate users.
    Lubman D; Koutsogiannis Z; Kronborg I
    Drug Alcohol Rev; 2003 Dec; 22(4):433-6. PubMed ID: 14660133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Questionnaire study of general practitioners regarding experience and attitude to opioid substitution therapy].
    Mravcík V; Coufalová M; Popov P; Zábranský T; Procházka R
    Epidemiol Mikrobiol Imunol; 2005 Feb; 54(1):27-33. PubMed ID: 15810140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of maintenance treatments on social life. A study with general practitioners].
    Bilal S; Menares J; De La Selle P; Toufik A; Perdrieux Y
    Ann Med Interne (Paris); 2003 Nov; 154 Spec No 2():S6-14. PubMed ID: 14760222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Follow-up of opioid addicts treated with high-dose buprenorphine in a health care network. National retrospective study. Experience of French general physicians].
    De Ducla M; Gagnon A; Mucchielli A; Robinet S; Vellay A
    Ann Med Interne (Paris); 2000 Apr; 151 Suppl A():A27-32. PubMed ID: 10855374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
    Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M
    J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dependence on psychotropic drugs and substitution treatment: recent trends. The OPPIDUM study of the Centers for Evaluation and Information on Drug Dependence (CEIP), October 1997].
    Thirion X; Micallef J; Guet F; Delarozière JC; Arditti J; Huntsman A; Sanmarco JL; Lagier G
    Therapie; 1999; 54(2):243-9. PubMed ID: 10394261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.